Investorideas.com - #Cannabisstocks: Canopy (TSX: #WEED.TO) (NYSE: $CGC) Enters MOU with BC Liquor Distribution Branch to Supply British Columbian Market, @CanopyGrowth
Get the latest Cannabis and Hemp stock news from www.investorideas.com
Thursday, July 12, 2018
Investorideas.com - #Cannabisstocks: RISE (CSE: $RLSC.C) Closes Deal to Buy Cultivate Kind and Life Bloom Organics
Investorideas.com - #Cannabisstocks: RISE (CSE: $RLSC.C) Closes Deal to Buy Cultivate Kind and Life Bloom Organics
Get the latest Cannabis and Hemp stock news from www.investorideas.com
Get the latest Cannabis and Hemp stock news from www.investorideas.com
Investor Ideas #Potcasts: #Cannabis News and Stocks on the Move - TSX: $WEED.TO, NYSE: $CGC, TSX: $LEAF.TO, CSE: $HIKU.C, TSXV: $WMD.V, CSE: $CRZ.C
Investor Ideas #Potcasts: #Cannabis News
and Stocks on the Move - TSX: $WEED.TO,
NYSE: $CGC, TSX: $LEAF.TO, CSE: $HIKU.C, TSXV: $WMD.V, CSE: $CRZ.C
July 12th Potcast
sponsored by Lexaria Bioscience Corp. ( CSE: $LXX.C ) (OTC: $LXRP) and its disruptive
drug delivery platform: DehydraTECH
Pt. Roberts, WA; Delta, BC –July 12, 2018
(Investorideas.com Newswire) www.Investorideas.com, a global news source
covering leading sectors including marijuana and hemp stocks and its “potcast’
site, www.potcasts.ca release today’s edition of its series, Investorideas.com potcastsCM -
cannabis news and stocks to watch plus insight from thought leaders and experts.
Listen to the podcast:
Read this in full at http://www.investorideas.com/news/2018/cannabis/07125Potcasts-TSX-WEED-NYSE-CGC-LEAF-CSE-HIKU-WMD-CRZ.asp
Today’s podcast overview/transcript:
Good morning and welcome to another Investorideas.com potcast ; looking
at cannabis news, stocks to watch as well as insights from thought leaders and
experts.
Today’s potcast was sponsored by Kelowna based Lexaria Bioscience Corp trading on the CSE under symbol LXX and on
the OTC as LXRP. Lexaria has developed a new disruptive
drug delivery platform: DehydraTECH The Company’s patented technology changes
the way Active Pharmaceutical Ingredients (“APIs”) enter the body orally:
1) Masks unwanted tastes – eliminates the need for sugar-filled edibles.
2) Reduces time of onset – effects are felt within 15-20 min vs. 60-120
min.
3) Avoids first-pass liver metabolism
4) Increases bio-absorption by 5-10X
The Company’s DehydraTECH™ technology is patent-protected for multiple
APIs: Cannabidiol (CBD), Tetrahydrocannabinol (THC), Non-steroidal
anti-inflammatory drugs (NSAIDs) such as ibuprofen, Nicotine and Fat soluble
vitamins.
Today’s podcast features news
from Canopy Growth
Corporation trading on the TSX as WEED and the NYSE as CGC, MedReleaf
Corp. trading on the TSX as LEAF, Hiku Brands Company Ltd. trading on the
CSE as HIKU, WeedMD Inc. trading
on the TSX-Venture as WMD and the OTC
as WDDMF and CannaRoyalty Corp. trading
on the CSE as CRZ,
Canopy
Growth Corporation announced that cannabis grown in its Delta and Aldergrove
facilities, its other sites across the country, and products from its CraftGrow
partners will be sold in fine retailers, both government-operated and private,
across the province of British Columbia post-prohibition.
Canopy
Growth entered into a supply MOU with the BC Liquor Distribution Branch to make
available 5,719 kg of high-quality cannabis products in the first 12-months
following October 17, 2018. The quantity referenced is a delivery requirement
agreed to in the MOU, not an internal allocation.
"Investing
in a reliable, national production footprint early has made all the difference
as provincial partners assess potential supply sources," said Mark
Zekulin, President & Co-CEO. "We've established a strong presence in
BC with state-of-the-art greenhouse facilities in Delta and Aldergrove and we
can't wait to see the BC bud we're currently growing and harvesting at both
sites readily available on store shelves."
MedReleaf
Corp. today announced that it has also entered into a Memorandum of
Understanding ("MOU") with the British Columbia Liquor Distribution
Branch ("BCLDB") to supply the Province with high quality adult
recreational-use cannabis products.
Under the
terms of the MOU, MedReleaf has agreed to supply the BCLDB with
cannabis products in a variety of formats including dried flower and capsules.
MedReleaf will be represented on British Columbia's on-line and brick and
mortar retail outlets under the San Rafael '71, AltaVie and Woodstock
brands.
Hiku Brands
Company Ltd. has also completed a supply agreement with the British Columbia
Liquor Distribution Branch (BCLDB) to supply cannabis for the adult use market
once legalization takes place in October, 2018.
"At
DOJA, we believe that we cultivate exceptional hand-crafted cannabis to help
people find their balance and actualize personal freedom. We are committed to
minimizing our impact on nature with an eye towards natural, sustainable and
innovative growing principles. We are West Coast Contemporaries"
said Trent Kitsch, President of Hiku and Co-Founder of DOJA, whose roots go
back three generations in Kelowna.
Grown in one
of Canada's premier wine regions, Hiku's Okanagan Valley cannabis brand is
truly inspired by nature from the ground up. DOJA is focused on producing
top-quality, indoor grown cannabis to serve the adult market in Canada.
Management believes its small capacity and craft cannabis production will find
a premium place with Canada's active and healthy lifestyle communities.
WeedMD Inc. announced
that it has also entered into a memorandum of understanding with the British
Columbia (“BC”) Liquor Distribution Branch (“LDB”) to supply the province with high-quality, branded cannabis
products for sale in BC’s adult-use market.
CannaRoyalty Corp., a leading
North American cannabis products and brands company, announced today that it
has acquired the exclusive rights to distribute and manufacture Pacific Remedy
LLC's ("Pacific Remedy") industry-leading infused pre-rolls in
California. The Agreement also provides CannaRoyalty with the option to
purchase global brand rights for the premium infused pre-roll manufacturer.
Pacific
Remedy's hand-rolled-in-California infused pre-rolls are uniquely positioned as
one of the most exclusive, potent and flavourful available
CannaRoyalty's
growing manufacturing support platform provides local entrepreneurs like
Pacific Remedy the unique opportunity to cost-effectively expand through
CannaRoyalty's licensed statewide distribution network
CannaRoyalty Corp. also announced
that it has closed its previously-announced, fully marketed private placement
of unsecured convertible debentures for raising aggregate gross proceeds of
C$32,980,000. The Offering was comprised of up to 30,000 unsecured convertible
debentures of the Company at a price of $1,000 per Convertible Debenture. The
Agents also partially exercised their option to arrange for purchases of additional
Convertible Debentures, raising an additional $2.98 million in gross proceeds.
The proceeds from the Financing will be primarily used by the Company to expand
its footprint across California, as well as general corporate and working
capital purposes.
Investor ideas reminds
all listeners to read our disclaimers and disclosures on the
Investorideas.com website and this podcast is not an endorsement to buy
products or services or securities. Investors are reminded all investment
involves risk and possible loss of investment
Lexaria Bioscience Corp. has developed and
out-licenses its disruptive delivery technology that promotes healthier
ingestion methods, lower overall dosing and higher effectiveness of lipophilic
active molecules. Lexaria has multiple patents pending in over 40 countries
around the world and has patents granted in the USA and in Australia for
utilization of its DehydraTECHTM delivery technology. Lexaria's technology
provides increases in intestinal absorption rates; more rapid delivery to the
bloodstream; and important taste-masking benefits, for orally administered
bioactive molecules including cannabinoids, vitamins, non-steroidal
anti-inflammatory drugs (NSAIDs), nicotine and other molecules. www.lexariabioscience.com
Subscribe to the new cannabis podcast series:
Investorideas.com podcasts are also available on
iTunes, Google Play Music, Stitcher and Tunein.
Potcasts is now a certified word
mark Trademark on the blockchain through Cognate, Inc. CM
Certification-Registration Number: 10468217708
About Investorideas.com - News that Inspires
Big Ideas
Investorideas.com is
a meeting place for global investors, featuring news, stock directories, video,
company profiles, interviews and more in leading sectors.
Investorideas.com
cannabis/marijuana and hemp content now includes http://cannabisstocknews.blogspot.com on Blogger.com: the Investorideas.com news and stock
directory pages, a cannabis investor group on Linkedin.com , the 420 Cannabis
Investor ideas www.420cannabisinvestorideas.com, and the new AI site Global Cannabis Investing at www.Globalcannabisinvesting.com
Disclaimer/Disclosure: Investorideas.com is
a digital publisher of third party sourced news, articles and equity research
as well as creates original content, including video, interviews and articles.
Original content created by investorideas is protected by copyright laws other
than syndication rights. Our site does not make recommendations for purchases
or sale of stocks, services or products. Nothing on our sites should be
construed as an offer or solicitation to buy or sell products or securities.
All investment involves risk and possible loss of investment. This site is
currently compensated for news publication and distribution, social media and
marketing, content creation and more. Contact each company directly regarding
content and press release questions. Disclosure is posted for each compensated
news release, content published /created if required but otherwise the news was
not compensated for and was published for the sole interest of our readers and
followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp. Disclosure Lexaria
Bioscience Corp. ( CSE: LXX) (OTC: LXRP) is a media sponsor of the podcast
starting July 5 2018 more info http://www.investorideas.com/About/News/Clientspecifics.asp
Additional info
regarding BC Residents and global Investors: Effective September 15 2008 - all
BC investors should review all OTC and Pink sheet listed companies for
adherence in new disclosure filings and filing appropriate documents with
Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations
of each country.
Follow us on Social Media
Contact Investorideas.com
800-665-0411
Wednesday, July 11, 2018
Investorideas.com - #Cannabisstocks: MedReleaf (TSX: $LEAF.V) receives EU GMP certification for shipment from its Markham facility and completes first export to Cannamedical Pharma in Germany
Investorideas.com - #Cannabisstocks: MedReleaf (TSX: $LEAF.V) receives EU GMP certification for shipment from its Markham facility and completes first export to Cannamedical Pharma in Germany
Get the latest Cannabis and Hemp stock news from www.investorideas.com
Get the latest Cannabis and Hemp stock news from www.investorideas.com
Investor Ideas #Potcasts; #Cannabis News and Stocks on the Move; TSX: $ACB.TO, CSE: $CRZ.C, CSE: $CROP.C, TSXV: $FIRE.V
Investor Ideas #Potcasts; #Cannabis
News and Stocks on the Move; TSX: $ACB.TO, CSE: $CRZ.C, CSE: $CROP.C, TSXV: $FIRE.V
July 11th Potcast
sponsored by Lexaria Bioscience Corp. ( CSE: $LXX.C ) (OTC: $LXRP) a #Cannabis
company with a new disruptive drug delivery platform: DehydraTECH
Pt. Roberts, WA; Delta, BC – July 11,
2018 (Investorideas.com Newswire) www.Investorideas.com, a global news source
covering leading sectors including marijuana and hemp stocks and its “potcast’
site, www.potcasts.ca release today’s edition of its series, Investorideas.com potcastsCM -
cannabis news and stocks to watch plus insight from thought leaders and experts.
Listen to the podcast:
Read this in full at http://www.investorideas.com/news/2018/cannabis/07112Potcasts-TSX-ACB-CSE-CRZ-CROP-FIRE.asp
Today’s podcast overview/transcript:
Good morning and welcome to another Investorideas.com potcast; looking
at cannabis news, stocks to watch as well as insights from thought leaders and
experts.
Today’s potcast was sponsored by Kelowna based Lexaria Bioscience Corp trading on the CSE under symbol LXX and on
the OTC as LXRP. Lexaria has developed a new disruptive
drug delivery platform: DehydraTECH The Company’s patented technology changes
the way Active Pharmaceutical Ingredients (“APIs”) enter the body orally:
1) Masks unwanted tastes – eliminates the need for sugar-filled edibles.
2) Reduces time of onset – effects are felt within 15-20 min vs. 60-120
min.
3) Avoids first-pass liver metabolism
4) Increases bio-absorption by 5-10X
The Company’s DehydraTECH™ technology is patent-protected for multiple
APIs: Cannabidiol (CBD), Tetrahydrocannabinol (THC), Non-steroidal
anti-inflammatory drugs (NSAIDs) such as ibuprofen, Nicotine and Fat soluble
vitamins.
Today’s podcast features news announcements from Aurora Cannabis Inc. (TSX:
ACB and OTCQB:
ACBFF) ,
CannaRoyalty Corp. (CSE:
CRZ) , CROP Infrastructure ( CSE:
CROP and OTC:
CRXPF) and The Supreme Cannabis Company (TSX-Venture:
FIRE) .
Aurora
Cannabis Inc. announced today the signing a binding term sheet with
CannaRoyalty Corp. (CSE: CRZ), whereby Aurora is purchasing CannaRoyalty's exclusive
Canadian license to use and commercialize pre-roll technology developed by
Wagner Dimas for an aggregate consideration of C$7 million in Aurora common
shares. Closing of the Agreement is subject to certain conditions, including
regulatory approval.
The
transaction includes cash and the issuance of common shares of Aurora relative
to the achievement of certain milestones for the joint commercialization of
Wagner Dimas's technology. This technology targets the high-volume,
higher-margin pre-rolled segment of the cannabis market.
Under the
terms of the agreement, Aurora and Wagner Dimas will form a new Canadian entity
to which Wagner Dimas has agreed to assign intellectual property with exclusive
rights to Aurora. The transaction is subject to completion of definitive
agreements, delivery of certain equipment from Wagner Dimas to Aurora -
expected within the next 21 days - as well as customary TSX and regulatory
approvals.
Aurora has
identified the pre-roll market segment as a high-volume, higher-margin
opportunity. BDS-Analytics, for instance, determined that pre-rolls account for
12% of total revenue generated from the adult consumer market in Washington
State (2017). Wagner Dimas produced over 5 million pre-rolls in 2017, and,
following scale-up to a new facility, the company is on pace to produce over 50
million pre-rolls in 2018 for the Californian market alone. Furthermore, the
Wagner Dimas technology enables the production of over 75 different pre-rolled
product types, addressing a wide variety of market demands. Wagner Dimas
provides pre-rolls to a wide range of the most popular brands in the California
market.
Aurora
Cannabis Inc. also announced today that it has established a partnership
agreement with Evio Beauty Group Ltd. pursuant to which Aurora has made a
strategic investment in Evio Beauty. Under the terms of the Agreement, Aurora
and Evio Beauty Group will collaborate to develop a line of co-branded hemp
seed oil cosmetic products ("Non-Infused Products") as well as a collection
of CBD infused cosmetic products ("Infused Products").
The
partnership between Evio Beauty and Aurora is aimed at creating a new line of
approved hemp seed oil based product formulations, as well as approved CBD
based products. Aurora and Evio Beauty anticipate that the partnership will
result in greater brand recognition and cross-selling opportunities to
customers of both companies.
CROP Infrastructure Corp. announced
its 30% owned Italy Joint Venture partner 'XHemplar Italia' has planted 25
acres or 1,089,000 square feet of high CBD 'Cannabis Light' in North Eastern
Italy. This represents over a 100% increase on the previously announced
capacity announced in press release dated June 27th 2018.
The Joint
Venture's resulting high CBD "Cannabis Light" will be processed and
sold into international CBD markets under white label, the venture's house name
XHemplar and Crop brands Tiffany CBD and Hempire Italia. The company will also
use the production to infuse its recently announced therapeutic and cosmetic
product lines, licensed from The Yield Growth Corp., which transaction is now
complete giving Crop exclusive rights in Italy to over 55 wellness products.
According to
Arcview Market Research and its partner, BDS Analytics, government-subsidized
healthcare spending (worldwide market at $1.3-trillion) is expected to make
Europe among the fastest growing and largest medical cannabis markets in the
world. Arcview expects Italy to be the second largest cannabis market in Europe
by 2027 with $1.2 billion in sales.
The Supreme
Cannabis Company today announced that it has obtained Health Canada approval to
commence cultivation on approximately 30,000 square feet of additional
flowering rooms at its 7ACRES facility. The new capacity is expected to double
7ACRES' estimated annual production from 5,000kg to 10,000kg.
The
proprietary technology and modular design of 7ACRES' facility has allowed for
the rapid scaling of operations while maintaining industry-leading product
quality, production standards and minimizing execution risk.
Total
completion of growing rooms at the 342,000-square foot 7ACRES facility is on
schedule for completion in December 2018.
Investor ideas reminds
all listeners to read our disclaimers and disclosures on the
Investorideas.com website and this podcast is not an endorsement to buy
products or services or securities. Investors are reminded all investment
involves risk and possible loss of investment
Lexaria Bioscience Corp. has developed and out-licenses
its disruptive delivery technology that promotes healthier ingestion methods,
lower overall dosing and higher effectiveness of lipophilic active molecules.
Lexaria has multiple patents pending in over 40 countries around the world and
has patents granted in the USA and in Australia for utilization of its
DehydraTECHTM delivery technology. Lexaria's technology provides increases in
intestinal absorption rates; more rapid delivery to the bloodstream; and
important taste-masking benefits, for orally administered bioactive molecules
including cannabinoids, vitamins, non-steroidal anti-inflammatory drugs
(NSAIDs), nicotine and other molecules. www.lexariabioscience.com
Subscribe to the new cannabis podcast series:
Investorideas.com podcasts are also available on
iTunes, Google Play Music, Stitcher and Tunein.
Potcasts is now a certified word
mark Trademark on the blockchain through Cognate, Inc. CM
Certification-Registration Number: 10468217708
About Investorideas.com - News that Inspires
Big Ideas
Investorideas.com is
a meeting place for global investors, featuring news, stock directories, video,
company profiles, interviews and more in leading sectors.
Investorideas.com
cannabis/marijuana and hemp content now includes http://cannabisstocknews.blogspot.com on Blogger.com: the
Investorideas.com news and stock directory pages, a cannabis investor group on
Linkedin.com , the 420 Cannabis Investor ideas www.420cannabisinvestorideas.com, and the new AI site Global Cannabis Investing at www.Globalcannabisinvesting.com
Disclaimer/Disclosure: Investorideas.com is
a digital publisher of third party sourced news, articles and equity research
as well as creates original content, including video, interviews and articles.
Original content created by investorideas is protected by copyright laws other
than syndication rights. Our site does not make recommendations for purchases
or sale of stocks, services or products. Nothing on our sites should be
construed as an offer or solicitation to buy or sell products or securities.
All investment involves risk and possible loss of investment. This site is
currently compensated for news publication and distribution, social media and
marketing, content creation and more. Contact each company directly regarding
content and press release questions. Disclosure is posted for each compensated
news release, content published /created if required but otherwise the news was
not compensated for and was published for the sole interest of our readers and
followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp. Disclosure Lexaria
Bioscience Corp. ( CSE: LXX) (OTC: LXRP) is a media sponsor of the podcast
starting July 5 2018 more info http://www.investorideas.com/About/News/Clientspecifics.asp
Additional info
regarding BC Residents and global Investors: Effective September 15 2008 - all
BC investors should review all OTC and Pink sheet listed companies for adherence
in new disclosure filings and filing appropriate documents with Sedar. Read for
more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations
of each country.
Follow us on Social Media
Contact Investorideas.com
800-665-0411
Subscribe to:
Posts (Atom)